Search

The Biscayan biopharmaceutical company, which plans to launch its first biological medicine into the market in the first half of 2025, will use the funds to expand its manufacturing capacity and

The main objective of the project is the creation of innovative in vitro models using microencapsulation of human liver cells by means of bioprinting systems.

In addition to this rating, earlier this year, CDP recognized the company for its transparency and efforts against climate change.

The conference held in Switzerland is one of Europe's benchmark events in the biotechnology sector, attracting professionals from the global life sciences community.

Immunobiogram is an in vitro diagnostic device that allows physicians to optimize immunosuppressive therapy on an individualized basis in renal transplant patients.

Ane Insausti, Deputy for Economic Promotion and Strategic Projects of the Provincial Council of Gipuzkoa, analyzes the commitment of the Basque Country to innovation and biotechnology.

The company has also announced that its launch is coming soon.

Biotechnology has achieved significant advances in diagnosis and precision therapies, the production of biotechnological drugs, and the treatment and understanding of infectious, autoimmune, and

Under the title “Linking the ubiquitin family: physiology, disease and future directions”, SEBBM, together with the Fundación Carmen y Severo Ochoa, is organizing the second Severo Ochoa Conference on

The regional government of Castilla y León authorized Bioxytol to develop its projects in Árevalo, Ávila, after evaluating and considering that its development implies a minimum environmental impact.

Next-generation DNA sequencing has a significant impact on personalized medicine, genomic research, and the identification of genetic diseases.

The three companies, members of AseBio, work every day to improve treatments and patients' lives through rapid diagnosis of infectious diseases, intestinal microbiota, and precision oncology.